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Background:  Early intervention with cardiac resynchronization therapy with defibrillator (CRT-D) in mild heart failure (HF) patients with a 
left bundle branch block (LBBB) ECG pattern was associated with a significant reduction in death and HF in the long-term MADIT-CRT trial. 
Whether patients in MADIT-CRT enrolled from centers in the United States (U.S.) and in Europe have different long-term clinical response 
to CRT-D remains unknown.
methods:  We compared the baseline clinical characteristics and clinical and echocardiographic long-term clinical response to CRT-D 
between MADIT-CRT patients with LBBB who were enrolled in U.S. (n=871) and European centers (n=392).
results:  Although European patients had more advanced heart disease than U.S. patients, CRT-D was associated with similar 60% 
(p<0.001) reductions in the risk of heart failure in U.S and European patients when compared to ICD-only therapy after adjustment for 
relevant baseline clinical covariates. U.S patients had significant long-term mortality reduction (38%, p=0.02) while among European 
patients the survival benefit associated with CRT-D was not statistically significant (HR=0.73p=0.18); Subgroup analyses revealed a 
significantly greater CRT-D benefit among women who were enrolled in the U.S, whereas no gender difference in the clinical benefit of 
CRT-D was observed in the European cohort. Percent reduction in left ventricular end systolic volume at 1-year was 36% and 33% among 
US and European patients, respectively.
conclusion:  Despite differences in baseline disease severity, European and U.S. patients with LBBB experienced a similar clinical and 
echocardiographic response to cardiac resynchronization therapy during long-term follow-up.
